Beta-1,3/1,6-D-Glucan
Showing 1 - 25 of >10,000
Uveitis Trial in Jakarta Pusat (Beta-1,3/1,6-D-Glucan Ganoderma lucidum, Placebos)
Recruiting
- Uveitis
- Beta-1,3/1,6-D-Glucan Ganoderma lucidum
- Placebos
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSCM Kirana
Feb 1, 2021
Venous Leg Ulcer Trial in United States (0.1% TR 987, Placebo gel)
Unknown status
- Venous Leg Ulcer
- 0.1% TR 987
- Placebo gel
-
Los Angeles, California
- +8 more
Oct 21, 2020
Cardiometabolic Syndrome Trial in Malang (ß-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group,
Enrolling by invitation
- Cardiometabolic Syndrome
- β-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group
- Placebo Group
-
Malang, East Java, IndonesiaGeneral Hospital of Brawijaya University (Rumah Sakit Universita
Oct 3, 2021
Invasive Fungal Infections Trial (procalcitonin ,CRP and 1, 3- ß -D- glucan in early diagnosis of invasive infections)
Not yet recruiting
- Invasive Fungal Infections
- procalcitonin ,CRP and 1, 3- β -D- glucan in early diagnosis of invasive infections
- (no location specified)
Feb 10, 2023
Ulcerative Colitis Trial in Jakarta (Beta-1,3/1,6-D-Glucan, Placebo)
Unknown status
- Ulcerative Colitis
- Beta-1,3/1,6-D-Glucan
- Placebo
-
Jakarta, Jakarta Pusat, IndonesiaRSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)
Jul 31, 2019
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States
Suspended
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 10, 2022
Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloid Neoplasm
- Biospecimen Collection
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Hyperlipidemias Trial in Montreal (CP105F, Placebo)
Completed
- Hyperlipidemias
- CP105F
- Placebo
-
Montreal, Quebec, CanadaMontreal Heart Institute
Jan 14, 2022
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2023
Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 10, 2022
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin
Recruiting
- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia
- Cyclophosphamide
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022
Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- odetiglucan
- CDX-1140
- (no location specified)
Jul 29, 2022
Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Not yet recruiting
- Copd Patients
- IL B,IL 3 in nasal swap and serum
- (no location specified)
Aug 4, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in
Terminated
- Philadelphia Chromosome Negative
- +2 more
- Blinatumomab
- +11 more
-
Houston, TexasM D Anderson Cancer Center
Nov 3, 2022
FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston
Active, not recruiting
- FLT3 Gene Mutation Negative
- +7 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 18, 2022
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6
Withdrawn
- Recurrent Diffuse Large B-Cell Lymphoma
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Asthma Trial in Canada (Vitamin D, Placebo)
Recruiting
- Asthma
- Vitamin D
- Placebo
-
Vancouver, British Columbia, Canada
- +8 more
Jan 30, 2023